“COMPARISON OF RESPONSE RATE OF SORAFENIB VS LENVATINIB IN HEPATOCELLULAR CARCINOMA PATIENTS ”. Frontier in Medical and Health Research 3, no. 6 (August 1, 2025): 2142–2148. Accessed May 1, 2026. https://fmhr.net/index.php/fmhr/article/view/2334.